| Literature DB >> 25092512 |
Kiyomi Tsuyuki1, Hilary L Surratt, Maria A Levi-Minzi, Catherine L O'Grady, Steven P Kurtz.
Abstract
The diversion of antiretroviral medications (ARVs) has implications for the integrity and success of HIV care, however little is known about the ARV illicit market. This paper aimed to identify the motivations for buying illicit ARVs and to describe market dynamics. Semi-structured interviews (n = 44) were conducted with substance-involved individuals living with HIV who have a history of purchasing ARVs on the street. Grounded theory was used to code and analyze interviews. Motivations for buying ARVs on the illicit market were: to repurchase ARVs after having diverted them for money or drugs; having limited access or low quality health care; to replace lost or ruined ARVs; and to buy a back-up stock of ARVs. This study identified various structural barriers to HIV treatment and ARV adherence that incentivized ARV diversion. Findings highlight the need to improve patient-provider relationships, ensure continuity of care, and integrate services to engage and retain high-needs populations.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25092512 PMCID: PMC4318775 DOI: 10.1007/s10461-014-0856-2
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165